Internal Medicine, Endocrinology, Diabetes, & Metabolism · Mayaguez, PR
NPI
1124433909
Since 2014
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
Mayaguez Medical Center, 410 Hostos Ave. Suite 112
Mayaguez, PR, 00680
Phone (787) 224-2269
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,543
62 services
Medicare patients, 2024
38
Average age 72
Drug cost, 2024
$2.5M
10,766 prescriptions
Company payments, 2025
$358
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rose M Roman Torres was code 99213 (office e&m - established), 47 times for 32 patients. In total Rose M Roman Torres billed 62 services in 4 codes, and Medicare paid $4,543.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-05-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 47 | 32 | $70.45 | $3,311 |
| 99214 Office E&M - Established | Office | 12 | 11 | $91.65 | $1,100 |
By year: 2022 $7,494 for 98 services; 2023 $6,190 for 82 services; 2024 $4,543 for 62 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rose M Roman Torres prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 1,615 prescriptions and refills. In total Rose M Roman Torres wrote 10,766 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 1,615 | 3,801 | 458 | $164K |
| Rosuvastatin Calcium Generic | 802 | 2,098 | 289 | $13K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 530 | 611 | 99 | $54K |
| Atorvastatin Calcium Generic | 462 | 1,028 | 146 | $4,588 |
| Metformin Hcl Er Metformin Hcl | 404 | 860 | 121 | $6,936 |
| Humalog Insulin Lispro | 394 | 475 | 74 | $64K |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 373 | 387 | 53 | $233K |
| Levothyroxine Sodium Generic | 331 | 775 | 112 | $4,524 |
| Glimepiride Generic | 318 | 702 | 90 | $8,334 |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 317 | 343 | 52 | $220K |
| Trulicity Dulaglutide | 282 | 294 | 44 | $291K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 230 | 250 | 44 | $155K |
| Metformin Hcl Generic | 221 | 511 | 81 | $1,624 |
| Glipizide Er Glipizide | 219 | 489 | 68 | $5,719 |
| Farxiga Dapagliflozin Propanediol | 216 | 294 | 61 | $171K |
Brand drugs: 5,779 claims; generic drugs: 4,407 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rose M Roman Torres $358 ($358 in general payments such as food, travel and fees) from 4 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $142.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.